Monthly Archives: July 2017

North American Bancard closes on Total Merchant Services deal – Crain’s Detroit Business

Posted: July 11, 2017 at 10:19 pm

North American Bancard Holdings LLC completed its acquisition of Woodland Hills, Calif.-based Total Merchant Services Inc., NAB announced Tuesday.

The sale closed June 30, NAB spokeswoman Brooke Tajer told Crain's in an email.

Terms of the deal were not disclosed.

The deal makes the Troy-based company the seventh largest payment processor on the continent, in terms of merchant locations, with $50 billion in annual processing. TMS will operate as a brand under single leadership as part of NAB, Tajer said.

With the merger, NAB gets a more than $12 billion boost in annual credit and debit card transactions in the short term, while TMS gets access to NAB's processing solutions, merchant and sales partner portals, onboarding tools and operational resources, the news release said. It will make way for NAB to expand its products, enter high-growth channels and improve payment solutions for businesses.

"This acquisition enables TMS to accelerate its development of fully integrated and secure payment solutions, continue its commitment to exemplary customer service for merchants and partners, and gain access to NAB's broad platform of capabilities," TMS founder and Chairman Ed Freedman said in a statement.

New York City-based Skadden, Arps, Slate, Meagher & Flom LLP and Westport, Conn.-based Berkowitz, Trager & Trager LLC advised TMS in the deal. Detroit-based Honigman Miller Schwartz and Cohn LLP advised NAB, Crain's reported in May.

Go here to read the rest:

North American Bancard closes on Total Merchant Services deal - Crain's Detroit Business

Posted in Tms | Comments Off on North American Bancard closes on Total Merchant Services deal – Crain’s Detroit Business

A Deep Dive into The Numbers For EDAP TMS SA (NasdaqGM:EDAP) – Ozark Times

Posted: at 10:19 pm

The Return on Invested Capital (aka ROIC) Score for EDAP TMS S.A. (NasdaqGM:EDAP) is -0.083832. The Return on Invested Capital is a ratio that determines whether a company is profitable or not. It tells investors how well a company is turning their capital into profits. The ROIC is calculated by dividing the net operating profit (or EBIT) by the employed capital. The employed capital is calculated by subrating current liabilities from total assets. Similarly, the Return on Invested Capital Quality ratio is a tool in evaluating the quality of a companys ROIC over the course of five years. This is calculated by dividing the five year average ROIC by the Standard Deviation of the 5 year ROIC. The ROIC 5 year average is calculated using the five year average EBIT, five year average (net working capital and net fixed assets).

EDAP TMS S.A. (NasdaqGM:EDAP) has a Price to Book ratio of 3.348311. This ratio is calculated by dividing the current share price by the book value per share. Investors may use Price to Book to display how the market portrays the value of a stock. Checking in on some other ratios, the company has a Price to Cash Flow ratio of 73.163146, and a current Price to Earnings ratio of 21.309099. The P/E ratio is one of the most common ratios used for figuring out whether a company is overvalued or undervalued.

Checking in on some valuation rankings, EDAP TMS S.A. (NasdaqGM:EDAP) has a Value Composite score of 58. Developed by James OShaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 66.

Watching some historical volatility numbers on shares of EDAP TMS S.A. (NasdaqGM:EDAP), we can see that the 12 month volatility is presently 39.612700. The 6 month volatility is 46.006400, and the 3 month is spotted at 54.452800. Following volatility data can help measure how much the stock price has fluctuated over the specified time period. Although past volatility action may help project future stock volatility, it may also be vastly different when taking into account other factors that may be driving price action during the measured time period.

Price Index We can now take a quick look at some historical stock price index data. EDAP TMS S.A. (NasdaqGM:EDAP) presently has a 10 month price index of 1.10274. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 0.99690, the 24 month is 0.96119, and the 36 month is 0.55326. Narrowing in a bit closer, the 5 month price index is 1.03205, the 3 month is 1.29317, and the 1 month is currently 1.05921.

Score The Gross Margin Score is calculated by looking at the Gross Margin and the overall stability of the company over the course of 8 years. The score is a number between one and one hundred (1 being best and 100 being the worst). The Gross Margin Score of EDAP TMS S.A. (NasdaqGM:EDAP) is 11.00000. The more stable the company, the lower the score. If a company is less stable over the course of time, they will have a higher score.

See the article here:

A Deep Dive into The Numbers For EDAP TMS SA (NasdaqGM:EDAP) - Ozark Times

Posted in Tms | Comments Off on A Deep Dive into The Numbers For EDAP TMS SA (NasdaqGM:EDAP) – Ozark Times

DARPA invests further in neurotechnology – SD Times – SDTimes.com

Posted: at 10:18 pm

The Defense Advanced Research Projects Agency (DARPA) wants to expand neurotechnology capabilities and create a high-resolution neural interface. The agency announced it is awarding contracts to five research organizations and one company as part of its Neural Engineering System Design (NESD) program.

DARPA announced NESD in January of 2016. The program was created to provide a connection between the brain and digital world.

DARPA has invested hundreds of millions of dollars transitioning neuroscience into neurotechnology with a series of cumulatively more advanced research programs that expand the frontiers of what is possible in this enormously difficult domain. Weve laid the groundwork for a future in which advanced brain interface technologies will transform how people live and work, and the agency will continue to operate at the forward edge of this space to understand how national security might be affected as new players and even more powerful technologies emerge, Justin Sanchez, director of DARPAs Biological Technologies Office.

The contracts will go to: Brown University; Columbia University; Fondation Voir et Entendre (The Seeing and Hearing Foundation); John B. Pierce Laboratory; Paradromics, Inc.; and the University of California, Berkeley.

The organizations will form teams dedicated to creating working systems that support sensory restoration world. According to the agency, four of the teams will focus on vision while two will focus on hearing and speech.

Significant technical challenges lie ahead, but the teams we assembled have formulated feasible plans to deliver coordinated breakthroughs across a range of disciplines and integrate those efforts into end-to-end systems, said Phillip Alvelda, the founding NESD program manager.

The programs first year will focus on breakthroughs in hardware, software, and neuroscience. The second phase of the program will look into properly testing newly developed devices. Achieving the programs ambitious goals and ensuring that the envisioned devices will have the potential to be practical outside of a research setting will require integrated breakthroughs across numerous disciplines including neuroscience, synthetic biology, low-power electronics, photonics, medical device packaging and manufacturing, systems engineering, and clinical testing, according to NESDs website.

View post:

DARPA invests further in neurotechnology - SD Times - SDTimes.com

Posted in Neurotechnology | Comments Off on DARPA invests further in neurotechnology – SD Times – SDTimes.com

Infinitely Flexible 3D Printing with Ultrasonic Manipulation? – ENGINEERING.com

Posted: at 10:18 pm

3D printing is an exciting technology in its own right, but, as it works today, it is normally used to fabricate individual components and not functional objects. At most, hundreds of parts in an assembly can be consolidated into a single 3D-printed item, but that item still cannot function on its own.

Progress is being made to change additive manufacturing (AM) technology into something even more powerful, however. In the future, it may be possible to fabricate complete functional objects in a single manufacturing process. Think of it: your smartphone could be produced in one piece in one automatic process.

One company has demonstrated a possible route to that ideal future. Using a unique ultrasonic technique, Neurotechnology, based out of Lithuania, may be able to 3D print a wide variety of objects, including circuits. ENGINEERING.com spoke to Osvaldas Putkis, research engineer and project lead for the companys Ultrasound Research Group, to learn more.

Neurotechnology is focused on developing algorithms and software for biometric applications, such as fingerprint, face, eye and voice recognition. Since launching its first fingerprint identification system in 1991, Neurotechnology has begun exploring other technologies, beginning research into artificial intelligence (AI), computer vision and autonomous robotics in 2004.

While Neurotechnologys core business is in the fields of biometry, computer vision and AI, it is always looking for opportunities to research and develop new technologies that sometimes can be outside the main companys focus, Putkis said. Ultrasonic manipulation seemed an exciting research area with an unused potential and, with the hiring of key personnel who have expertise in ultrasound, an Ultrasound Research Group was created three years ago.

Ultrasonic manipulation? No, its not a sleazy method for picking up strangers at a bar from the dirt bags that brought you those pickup artist guides. It involves using ultrasonic waves to grab and move objects.

A rendering of Neurotechnologys ultrasonic manipulation technique. (Image courtesy of Neurotechnology/YouTube.)

Typically, according to Putkis, most of the research and development in ultrasonic manipulation has been dedicated to liquid media for for cell sorting, cell patterning, [and] single cell manipulation. Applied research on manipulation in air, Putkis said, concentrates on container-less processing and analysis of chemical substances by levitating the samples.

After establishing the Ultrasound Research Group in 2014, the company developed a working prototype, finally releasing footage of its ultrasonic manipulation technique this past June. The process uses a computer with computer vision and an array of ultrasonic transducers, each of which can be controlled individually to grab, move and rotate components by changing the ultrasonic waves they emit.

In the demonstration video embedded above, the system has been set up to position and solder electronic components on a printed circuit board (PCB). Soldering is performed using an onboard laser that fuses the pieces onto the PCB, and is guided by the vision system. Altogether, there is no physical contact made with the objects being moved and soldered, opening up a number of possibilities.

Neurotechnologys ultrasonic manipulation prototype 3D printer. (Image courtesy of Neurotechnology/YouTube.)

"Ultrasonic manipulation can handle a very large range of different materials, including metals, plastics and even liquids," Putkis said."Not only can it manipulate material particles, it can also handle components of various shapes. Other noncontact methods, like the ones based on magnetic or electrostatic forces, can't offer such versatility."

This range of material manipulation, not seen with other technologies like magnetic or electrostatic techniques, means that the technology can print with elements that have a variety of shapes and mechanical properties. This includes liquids, such as conductive ink, and solids, like electronic components. These elements can range from a couple of millimeters in size to submillimeter particles. And ultrasonic manipulation can do this without causing any damage to the elements or introducing electrostatic forces into the process.

Ultrasonic manipulation can control a wide variety of substances, shapes and sizes. (Images courtesy of Neurotechnology/YouTube.)

By altering the ultrasonic profile of the process, the precision of object movement and placement can become highly refined. With ultrasonic waves of 40 kHz, its possible to attain accuracies of within tens of microns. Even higher frequencies result in even more precise movement.

Putkis explained that there may be weight restrictions with the ultrasonic transducers, but that this may not always be the case when the density of the elements is taken into consideration. [Pa]rticle dimensions should be in a sub-wavelength region of the ultrasonic waves used, Putkis said. In terms of weight, it is usually the density of the material that is the determining factor. You will need to create very similar pressure amplitude in order to levitate a 1-millimeter diameter or a 2-millimeter diameter plastic sphere. While the gravity force is bigger for a larger sphere, a larger sphere also has a larger surface area, increasing pressure force respectively. With our semisphere levitator shown in the video, we can levitate materials as dense as solder metal (approx. 8000 kg/m3).

The technology is also already fairly automated. The camera is capable of determining the PCBs position and orientation, making it possible to know where a component should be positioned. The circuits used in the companys demonstration are not overly complex and do not have many elements. Therefore, the trajectories can easily be calculated, according to Putkis.

Neurotechnology has already filed a patent for the technology and is continuing to develop its capabilities. At the moment, the system can only assemble simple electronics, so the Ultrasound Research Group intends to expand the platform.

[O]ur plans now are to develop and demonstrate capabilities of the technology to print/deposit other materials or components, Putkis explained. As our main expertise is in ultrasound, we are willing to cooperate with companies from the 3D printing industry in order to incorporate the technology in 3D printing systems.

If we are successful in adding the capability of printing plastics and improving the current prototype for electronic assembly, it would already be a powerful printer that can print some of the electronic devices, Putkis added. Another application could be to use ultrasonic manipulation just for component handling and integrate it to existing printing technologies of plastics or metal, in this way also creating a more universal printer.

To make the platform as flexible as possible, Putkis noted one specific challenge. The biggest challenges are finding methods for dispensing and soldering material and components that can work for a wide range of different components and materials in order to make full use of the handling versatility of ultrasonic manipulation, he said.

It would be interesting to see Neurotechnology partner with 3D printing companies already focused on electronics 3D printing. Two immediately come to mind: Voxel8 and Nano Dimension. Voxel8 has developed a fused deposition modeling desktop 3D printer that is capable of printing plastic parts with conductive silver ink traces, making it possible to manually embed electronic components to create functional objects. Nano Dimension, in contrast, relies on an inkjet printhead and photocurable resin to produce PCBs.

In both cases, electronic components must be manually inserted. Its not impossible to imagine incorporating an array of ultrasonic transducers into either platform in order to automatically move the components throughout the printbed as the fabrication process is taking place.

Facebook also recently scooped up a company, Nascent Objects, that was using EnvisionTECs digital light processing technology to 3D print functional electronic goods. Although we havent heard from the company in some time, the acquisition is an indicator that this field is a potentially highly valuable one. We may still be years away from being able to 3D print a complete cell phone in a single printing process, but even the steps along the way will be exciting ones, as Putkiss research shows.

To learn more about Neurotechnology, visit the company website.

Link:

Infinitely Flexible 3D Printing with Ultrasonic Manipulation? - ENGINEERING.com

Posted in Neurotechnology | Comments Off on Infinitely Flexible 3D Printing with Ultrasonic Manipulation? – ENGINEERING.com

The Hot Stock: CF Industries Gains 6.6% – Barron’s

Posted: at 10:17 pm


Barron's
The Hot Stock: CF Industries Gains 6.6%
Barron's
CF Industries (CF) rose to the top of the S&P 500 today, helped by overall bullishness in the fertilizer sector. Illustration: Pixabay. CF Industries climbed $1.83 cents, or 6.6%, to $29.72, while the S&P 500 gained 2.25 point,s or 0.09%, to 2427.43 ...

Continued here:

The Hot Stock: CF Industries Gains 6.6% - Barron's

Posted in Cf | Comments Off on The Hot Stock: CF Industries Gains 6.6% – Barron’s

Phase 3 Study of Sollpura, Enzyme Replacement Therapy for CF Patients with EPI, Recruiting in Europe and US – Cystic Fibrosis News Today

Posted: at 10:17 pm

APhase 3 studyof Sollpura (liprotamase), anon-porcine enzyme replacement therapy aiming to treatexocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF) better than existing porcine-derived therapies, is now recruiting about 150 pediatricand adultpatientsin the United States, Europe and Israel.

Specifically, theexpandedtrialwillevaluate the efficacy or non-inferiority of Sollpura compared to pig-derived and enteric-coated pancreatic enzyme replacement therapies (PERTs) approved for CF patients with EPI, a condition caused by low enzyme levels in the digestive tract.Topline resultsare expected toward the end of 2017 or in early 2018.

As a PERT, Sollpura is beingdeveloped by Anthera to overcome nutrient malabsorption in CF patients due tochronic pancreatic inflammation and the thick mucus that blocks the discharge of pancreatic enzymes needed for digestion. It containsthe enzymes lipase, protease and amylase in a specific ratio designed to promote a healthy digestion of food. Because it is of non-porcine origin,Sollpuras therapeutic value should come without the risks associated withsimilar porcine-based drugs.

We are very much looking forward to supporting Anthera in their efforts to bring this novel, biotech-derived pancreatic enzyme replacement therapy to patients, Fernando Casals Seoane, MD, PhD, gastroenterology and hepatology specialist at Hospital Universitario de La Princesa, Madrid, said in a companypress release.

In a previous Phase 3 clinical study, calledSOLUTION (NCT02279498), researchers demonstrated the non-inferiority of Sollpura compared to Pancreaze, aporcine-derived PERT. The new clinical trial, RESULT (NCT03051490), will further assess the efficacy and safety of Sollpura capsules in comparison to thisPERT in CF patients with EPI, adjusting for dose frequency and levels as needed by an individual.

We have been involved with the Sollpura program since Anthera initiated its clinical development with the SOLUTION study and we are pleased that the RESULT study is now underway in Europe, said Amparo Sol Jover, MD, PhD, pulmonologist at Hospital La Fe de Valencia, also inSpain, and president of the Sociedad Espaola de Fibrosis Qustica.

The trial is expected to enroll about 150 patients, ages 7 and above, on a stable porcine PERT regime with well-controlled EPI, as measured by the coefficient of fat absorption (CFA). Participants will be randomized to receive either Sollpura or Pancreaze for four weeks. During the initial three weeks, researchers will conduct dose adjustments based on a patients symptoms and clinical evaluation to achieve the best therapeutic benefit.

Its primary endpoint, or objective, istreatment efficacy as seen in changes in CFA levels from baseline after four weeks of treatment. Those patients givenSollpura will be followed for an additional 20 weeks to evaluate long-term safety and efficacy.

Anthera also announced that the RESULT study was approved by theProtocol Review Committee of theCystic Fibrosis Foundations Therapeutics Development Network, which may bring further testing sites to this Phase 3 trial and aid in patient recruitment within the U.S.

Sollpura was also evaluated as a drinkable formulation (a powder for oral solution) in the Phase 3 SIMPLICITY clinical trial (NCT02734810). This power formulation mayprovide a more easy-to-administer source of PERT for pediatric patients and for those who receive their nutrition through feeding tubes.

For more information about the trial and how to participate, please visit this link.

Read more:

Phase 3 Study of Sollpura, Enzyme Replacement Therapy for CF Patients with EPI, Recruiting in Europe and US - Cystic Fibrosis News Today

Posted in Cf | Comments Off on Phase 3 Study of Sollpura, Enzyme Replacement Therapy for CF Patients with EPI, Recruiting in Europe and US – Cystic Fibrosis News Today

Post-CF project, Hard Rock revenues drop | Local news … – Sioux City Journal

Posted: at 10:17 pm

Iowa casinos revenue for FY 2017

Casino fiscal 2016 fiscal 2017

Ameristar/Council Bluffs

Adjusted Gross Revenue $168,960,868 $171,435,126

Admissions 1,896,714 1,856,303

Win Per Capita $89 $92

Casino Queen/Marquette (formerly Lady Luck)

Adjusted Gross Revenue $27,124,696 $26,384,268

Admissions 272,140 253,122

Win Per Capita $100 $104

Catfish Bend/Burlington

Adjusted Gross Revenue $43,838,051 $41,715,532

Admissions 756,663 668,883

Win Per Capita $58 $62

Diamond Jo/Dubuque

Adjusted Gross Revenue $67,561,683 $66,856,145

Admissions 977,925 917,395

Win Per Capita $69 $73

Diamond Jo Worth/Northwood

Adjusted Gross Revenue $86,539,765 $85,196,088

Admissions 1,266,893 1,237,613

Win Per Capita $68 $69

Grand Falls Casino Resort/Larchwood

Adjusted Gross Revenue $55,748,970 $54,802,316

Admissions 1,060,218 1,022,442

Win Per Capita $53 $54

Hard Rock/Sioux City

Adjusted Gross Revenue $83,178,970 $77,027,496

Admissions 1,958,105 1,721,017

Win Per Capita $42 $45

Harrahs Council Bluffs Casino & Hotel

Adjusted Gross Revenue $70,588,823 $71,271,483

Admissions 1,074,207 1,139,940

Win Per Capita $66 $63

Horseshoe Casino Council Bluffs

Adjusted Gross Revenue $175,623,055 $172,142,344

Admissions 1,996,594 2,016,310

Win Per Capita $88 $85

Isle of Capri/Bettendorf

Adjusted Gross Revenue $69,716,577 $77,459,196

Admissions 822,639 1,075,519

Win Per Capita $85 $72

Isle Casino Hote/Waterloo

Adjusted Gross Revenue $89,583,537 $87,034,926

Admissions 1,232,766 1,119,847

Win Per Capita $73 $78

Lakeside Casion/Osceola

Adjusted Gross Revenue $49,414,050 $48,135,113

Admissions 630,199 539,892

Win Per Capita $78 $89

Prairie Meadows Racetrack & Casino/Altoona

Adjusted Gross Revenue $182,515,752 $190,172,316

Admissions 2,926,388 3,155,137

Win Per Capita $62 $60

Q Casino/Dubuque (formerly Mystique)

Adjusted Gross Revenue $48,811,457 $47,639,628

Admissions 867,555 847,435

Win Per Capita $56 $56

Rhythm City Casino/Davenport

Adjusted Gross Revenue $43,913,493 $61,945,577

Admissions 751,346 1,274,293

Win Per Capita $58 $49

Riverside Casino & Golf Course

Adjusted Gross Revenue $85,207,663 $85,682,854

Admissions 1,550,010 1,524,135

Win Per Capita $55 $56

Wild Rose/Clinton

Adjusted Gross Revenue $32,924,975 $31,362,880

Admissions 576,176 567,370

Win Per Capita $57 $55

Wild Rose/Emmetsburg

Adjusted Gross Revenue $29,017,941 $28,420,748

Admissions 450,589 424,122

Win Per Capita $64 $67

Wild Rose/Jefferson

Adjusted Gross Revenue $26,865,904 $28,214,880

Admissions 471,306 442,626

Win Per Capita $57 $64

Totals

Adjusted Gross Revenue $1,437,136,230 $1,452,898,916

Admissions 21,583,433 21,803,401

Win Per Capita $67 $67

Source: Iowa State Racing and Gaming Commission

Read more:

Post-CF project, Hard Rock revenues drop | Local news ... - Sioux City Journal

Posted in Cf | Comments Off on Post-CF project, Hard Rock revenues drop | Local news … – Sioux City Journal

Attempted murder charge filed against CF teen accused of shooting two horses – Iron Mountain Daily News

Posted: at 10:17 pm

CRYSTAL FALLS A Crystal Falls teen accused of shooting two horses and an occupied home in Crystal Falls Township earlier this year now faces an attempted murder charge.

Iron County Prosecutor Melissa Powell on Thursday authorized the new charge, a life felony, as well as felony firearm, a two-year felony, against 19-year-old Luke Endjamin Wool.

Powell was unavailable this morning to provide additional information on the development. The amended criminal complaint lists Shawn Colberg as the attempted murder victim.

Previous charges against Wool include discharge a firearm in or at a building, a 10-year felony, and two counts of killing or torturing animals, a four-year felony.

Wools case in Iron County Trial Court has been on hold since April while he undergoes competency and criminal responsibility evaluations.

Wool reportedly told police he shot and killed a draft horse Feb. 24 in Crystal Falls Township while playing American Sniper,' then shot and injured a second horse March 16 because it laughed at him and draft horses are supposed to be in pairs, Powell said in a previous court hearing.

The horses belong to Chuck, Lisa and Jeff Battan.

Iron County deputies went to the March 16 incident after hearing of shots fired at a horse and a nearby occupied home. They were able to connect Wool with the horse found dead Feb. 24 after it broke a leg, severing a main artery.

Wool reportedly told police he listened in on a conversation between his pastor and the pastors wife, who he was living with, to figure out how to get into their gun safe. While the two were out of town, Wool reportedly took five guns and ammunition, according to Powell.

NEGAUNEE Michigan State Police troopers from the Negaunee post are investigating a report of two missing ...

TRAVERSE CITY, Mich. (AP) A two-week search turned up no additional Asian carp in a Chicago waterway where one ...

QUINNESEC Breitung Township will move up scheduled inspection and repairs to the Quinnesec water distribution ...

Read the original:

Attempted murder charge filed against CF teen accused of shooting two horses - Iron Mountain Daily News

Posted in Cf | Comments Off on Attempted murder charge filed against CF teen accused of shooting two horses – Iron Mountain Daily News

MedShape Launches the DynaFrame CF Deployment System for TTC Fusion Surgery – PR Newswire (press release)

Posted: at 10:17 pm

Clinically introduced in 2012, the DynaNail TTC Fusion System is the first and only internal fusion device to harness the pseudoelastic properties of NiTiNOL to offer the compression performance of an external fixator inside an intramedullary (IM) nail design. Compression has shown to be important in not only keeping the bones in close apposition but also in providing the physiological stresses needed to promote bone healing. DynaNail's internal NiTiNOL Compressive Element maintains post-operative compression by automatically adapting for up to 6 mm of bone resorption or settling. During surgery, DynaFrame CF is used to insert DynaNail and stretch the NiTiNOL Compressive Element. Once stretched, DynaFrame CF aids in targeting and placing fixation screws across the DynaNail Implant. The Compressive Element is then activated upon removal of DynaFrame CF.

The DynaFrame CF Deployment System is equipped with several new features from the original DynaNail Targeting Frame. In particular, the carbon fiber PEEK construction provides up to 18X more rigidity than the original PEEK material. Several geometry changes were also implemented including adding more clearance to the distal end of the DynaFrame and its posterior-anterior Targeting Arm to accommodate larger patient anatomies. The increased rigidity from the carbon fiber material along with these additional geometry changes eliminates any issues with drill targeting ensuring a fast, simple procedure every time.

"The release of the DynaFrame CF Deployment System represents an important milestone in DynaNail's commercial progression," said Jeremy Blair, MedShape Vice President of Research and Development. "Based on surgeon feedback, we recognized the need for a deployment system that reduces the number of surgical pearls, more reliably targets the drills, and was versatile for all patient populations. DynaFrame CF addresses these surgical needs with its robust design and carbon fiber material. With these instrumentation updates, the DynaNail TTC Fusion System now pairs intra-operative simplicity and speed with the already unrivaled clinical benefits of the DynaNail implant."

Indicated for use in tibiotalocalcaneal (TTC) fusion surgery, DynaNail has become an effective treatment option to address numerous pathologies, including Charcot neuroarthropathy, severe osteoarthritis, failed total ankle replacement and nonunion from previous arthrodesis procedures. While reported non-union rates with static IM nails are as high as 50%,1 DynaNail has demonstrated clinical success in even high-risk patients with poor healing capacity including diabetics and smokers.2,3

"I am pleased with the new DynaFrame and its ease of use during surgery," said John Kwon MD, Harvard Medical. "I have implanted many DynaNail devices and have been impressed with my patient outcomes to date. DynaNail gives me the confidence that even my most complex patients will receive the compression needed to achieve successful fusion."

For more information on DynaNail, please visit http://www.medshape.com/our-products/dynanail.html.

About MedShape, Inc.: MedShape, Inc. is a privately held medical device company working to develop and commercialize a portfolio of surgical solutions for foot and ankle and trauma surgeons that use its patented advanced material technologies. For more information, visit: http://www.medshape.com.

1Jeng CL, Campbell JT, Tang EY, Cerrato RA, Myerson MS. Tibiotalocalcaneal Arthrodesis with Bulk Femoral Head Allograft for Salvage of Large Defects in the Ankle. Foot and Ankle International, 2013; 34: 1256-1266.

2Latt LD, Dupont KM, Smith KE. Revision Tibiotalocalcaneal Arthrodesis with a Pseudoelastic Intramedullary Nail - A Case Study. Foot and Ankle Specialist, 2017; 10(1): 75-81.

3Hsu AR, Ellington JK, Adams SB, Jr. Tibiotalocalcaneal Arthrodesis Using a NiTiNOL Intramedullary Hindfoot Nail. Foot and Ankle Specialist, 2015; 8(5): 389-96.

DynaNail is a registered trademark of MedShape, Inc.

Media Contact: Jenn Pratt Carabiner Communications 678.313.3438 jpratt@carabinercomms.com

Company Contact: Kathryn Smith, Ph.D. 678.235.3304 Kathryn.smith@medshape.com

View original content:http://www.prnewswire.com/news-releases/medshape-launches-the-dynaframe-cf-deployment-system-for-ttc-fusion-surgery-300486132.html

SOURCE MedShape, Inc.

http://www.medshapesolutions.com

See the original post:

MedShape Launches the DynaFrame CF Deployment System for TTC Fusion Surgery - PR Newswire (press release)

Posted in Cf | Comments Off on MedShape Launches the DynaFrame CF Deployment System for TTC Fusion Surgery – PR Newswire (press release)

Digging Up the Facts on CF Industries Holdings, Inc. (CF) – StockNewsJournal

Posted: at 10:17 pm

Digging Up the Facts on CF Industries Holdings, Inc. (CF)
StockNewsJournal
CF Industries Holdings, Inc. (CF) is an interesting player in the Basic Materials space, with a focus on Agricultural Chemicals. The stock has been active on the tape, currently trading at $29.72, up from yesterday's close by 6.56%. Given the stock's ...

See the article here:

Digging Up the Facts on CF Industries Holdings, Inc. (CF) - StockNewsJournal

Posted in Cf | Comments Off on Digging Up the Facts on CF Industries Holdings, Inc. (CF) – StockNewsJournal